Sichuan Duorui Biopharmaceutical Co., Ltd.
CN
1 YR
Business licensed
Certified factory
CN
1 YR
Business licensed
Certified factory
Favorite Supplier
304 people visit
New Products
Main Categories
-
Weight management
-
Type two diabetes
Hot Products
Company Profile
Sichuan Duorui Biopharmaceutical Co., Ltd.
Established in 2018 and located in Jintang County, Chengdu, Sichuan Province, focuses on the R&D and production of peptide APIs. The company covers an area of 200,000 square meters, has a GMP production workshop, possesses advanced peptide drug preparation technology, and has large-scale peptide production capabilities, providing high-quality, low-cost, and fast-response product services. Main products: Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide, Teriparatide, etc. Capacity:Peptide for human use: 500 kg Peptide for Veterinary use: 200 kg Oct., 2024: "Albuvirtide" API passed the NMPA GMP compliance inspection.Aug. 2023: "Teriparatide" Injection"assembly line passed US FDA site inspection with no 483 observation.
Payment Terms:
TT against copy of documents,L/C,100% TT in advanceAverage lead Time:
Peak season lead time: within Workday; Off season lead time: within Workday
Business Type
Manufactory
Location
Sichuan, China
Year Established
2018
Total Employees
101-200
Total Annual Revenue
$5 million-$10 millionOur Exhibition
Main Products
Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan
Send an Inquiry
![公司图片-已美化.png]()
![公司图片-已美化.png]()
![门口照片.jpg]()
![公司图片.png]()
![55759fd1d5664cdbe00c911bee9ae36.jpg]()
![55759fd1d5664cdbe00c911bee9ae36.jpg]()
![5bb97cc4df98094f568f370a7ae9e288.jpg]()
![14f881f970b4ee51fc0c2cf44041105d.jpg]()
